# A Prospective Trial to Assess Breast Cancer Survivors and Vaginal Atrophy Treatment Outcomes

> **NCT03547089** · NA · SUSPENDED · sponsor: **W. Grant Stevens, MD** · enrollment: 10 (estimated)

## Conditions studied

- Vaginal Atrophy
- Genitourinary System; Disorder, Female
- Vaginal Abnormality
- Sexual Dysfunction
- Sexual Problem

## Interventions

- **DEVICE:** Viveve®

## Key facts

- **NCT ID:** NCT03547089
- **Lead sponsor:** W. Grant Stevens, MD
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** SUSPENDED
- **Start date:** 2018-08-01
- **Primary completion:** 2020-03-01
- **Final completion:** 2020-03-01
- **Target enrollment:** 10 (ESTIMATED)
- **Why stopped:** Recruitment issues
- **Last updated:** 2019-03-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03547089

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03547089, "A Prospective Trial to Assess Breast Cancer Survivors and Vaginal Atrophy Treatment Outcomes". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03547089. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*